Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo

Endocrine-Related Cancer

Volumn 16, Issue 2, 2009, Pages 415-428

  Ishii, Kenichiro ^a   Imamura, Tetsuya ^a   Iguchi, Kazuhiro ^b   Arase, Shigeki ^a   Yoshio, Yuko ^a   Arima, Kiminobu ^a   Hirano, Kazuyuki ^b   Sugimura, Yoshiki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANDROGEN; BETA ACTIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; VIMENTIN; FGFR1 PROTEIN, HUMAN; FGFR2 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CASTRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; ENZYME IMMUNOASSAY; GENETICS; MALE; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR CELL LINE; WESTERN BLOTTING;

ANDROGENS; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RATS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 67650507133     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0219     Document Type: Article

References (56)

1. Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Ohori M, Wheeler M, Spitler J & Rowley DR 2003 Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clinical Cancer Research 9 4792-4801.
2. Baldi E, Bonaccorsi L & Forti G 2003 Androgen receptor: good guy or bad guy in prostate cancer invasion? Endocrinology 144 1653-1655.
3. Bhowmick NA, Neilson EG & Moses HL 2004 Stromal fibroblasts in cancer initiation and progression. Nature 432 332-337.
4. Camps JL, Chang SM, Hsu TC, Freeman MR, Hong SJ, Zhau HE, von Eschenbach AC & Chung LW 1990 Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. PNAS 87 75-79.
5. Cano P, Godoy A, Escamilla R, Dhir R & Onate SA 2007 Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer. Cancer Research 67 511-519.
6. Chang SM & Chung LW 1989 Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology 125 2719-2727.
7. Chung LW, Baseman A, Assikis V & Zhau HE 2005 Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Journal of Urology 173 10-20.
8. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G & Klocker H 1994 Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Research 54 5474-5478.
9. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL & Foster BA 1992 Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. Journal of Andrology 13 465-475.
10. Cunha GR, Foster B, Thomson A, Sugimura Y, Tanji N, Tsuji M, Terada N, Finch PW & Donjacour AA 1995 Growth factors as mediators of androgen action during the development of the male urogenital tract. World Journal of Urology 13 264-276.
11. El Sheikh SS, Domin J, Abel P, Stamp G & Lalani el N 2004 Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF. Neoplasia 6 846-853.
12. Eyden B 2008 The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. Journal of Cellular and Molecular Medicine 12 22-37.
13. Finch PW, Rubin JS, Miki T, Ron D & Aaronson SA 1989 Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245 752-755.
14. Gowardhan B, West AF, Robson CN & Leung HY 2004 Adenovirus-mediated expression of a soluble fibroblast growth factor receptor inhibits in vitro growth of prostate DU145 cells. Prostate 61 50-59.
15. Gowardhan B, Douglas DA, Mathers ME, McKie AB, McCracken SR, Robson CN & Leung HY 2005 Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer. British Journal of Cancer 92 320-327.
16. Halin S, Hammarsten P, Wikstrom P & Bergh A 2007 Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment. Prostate 67 370-377.
17. Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M & Marini F 2007 Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. International Journal of Hematology 86 8-16.
18. Huggins C & Hodges CV 2002 Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate, 1941. Journal of Urology 168 9-12.
19. Iguchi K, Otsuka T, Usui S, Ishii K, Onishi T, Sugimura Y & Hirano K 2004 Zinc and metallothionein levels and expression of zinc transporters in androgen-independent subline of LNCaP cells. Journal of Andrology 25 154-161.
20. Iguchi K, Ishii K, Nakano T, Otsuka T, Usui S, Sugimura Y & Hirano K 2007 Isolation and characterization of LNCaP sublines differing in hormone sensitivity. Journal of Andrology 28 670-678.
21. Ishii K, Usui S, Sugimura Y, Yoshida S, Hioki T, Tatematsu M, Yamamoto H & Hirano K 2001 Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion. International Journal of Cancer 92 49-54.
22. Kalluri R & Zeisberg M 2006 Fibroblasts in cancer. Nature Reviews. Cancer 6 392-401.
23. Kanai M, Ishii K, Kanda H, Ogura Y, Kise H, Arima K & Sugimura Y 2008 Improvement in predicting tumorigenic phenotype of androgen-insensitive human LNCaP prostatic cancer cell subline in recombination with rat urogenital sinus mesenchyme. Cancer Science 99 2435-2443.
24. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R & Weinberg RA 2007 Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 557-563.
25. Kawada M, Inoue H, Masuda T & Ikeda D 2006 Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer. Cancer Research 66 4419-4425.
26. Koivisto P, Kolmer M, Visakorpi T & Kallioniemi OP 1998 Androgen receptor gene and hormonal therapy failure of prostate cancer. American Journal of Pathology 152 1-9.
27. Leung HY, Mehta P, Gray LB, Collins AT, Robson CN & Neal DE 1997 Keratinocyte growth factor expression in hormone insensitive prostate cancer. Oncogene 15 1115-1120.
28. Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ & Brodie AM 2000 Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Cancer Research 60 6630-6640.
29. Matsubara A, Yasumoto H & Usui T 1999 Hormone refractory prostate cancer and fibroblast growth factor receptor. Breast Cancer 6 320-324.
30. Micke P & Ostman A 2004 Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anticancer therapy? Lung Cancer 45 S163-S175.
31. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW & Banerjee D 2008 Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Research 68 4331-4339.
32. Nemeth JA, Zelner DJ, Lang S & Lee C 1998 Keratinocyte growth factor in the rat ventral prostate: androgen-independent expression. Journal of Endocrinology 156 115-125.
33. Niu Y, Xu Y, Zhang J, Bai J, Yang H & Ma T 2001 Proliferation and differentiation of prostatic stromal cells. BJU International 87 386-393.
34. Ogura Y, Ishii K, Kanda H, Kanai M, Arima K, Wang Y & Sugimura Y 2007 Bisphenol A induces permanent squamous change in mouse prostatic epithelium. Differentiation 75 745-756.
35. Ohlson N, Bergh A, Stattin P & Wikstrom P 2007 Castration-induced epithelial cell death in human prostate tissue is related to locally reduced IGF-1 levels. Prostate 67 32-40.
36. Onishi T, Yamakawa K, Franco OE, Kawamura J, Watanabe M, Shiraishi T & Kitazawa S 2001 Mitogen-activated protein kinase pathway is involved in alpha6 integrin gene expression in androgen-independent prostate cancer cells: role of proximal Sp1 consensus sequence. Biochimica et Biophysica Acta 1538 218-227.
37. Orimo A & Weinberg RA 2006 Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5 1597-1601.
38. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL & Weinberg RA 2005 Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121 335-348.
39. Planz B, Aretz HT, Wang Q, Tabatabaei S, Kirley SD, Lin CW & McDougal WS 1999 Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Prostate 41 233-242.
40. Planz B, Oltean H, Deix T, Kirley SD, Wang QF, McDougal WS & Marberger M 2004 Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP. World Journal of Urology 22 140-144.
41. Ronnov-Jessen L, Petersen OW, Koteliansky VE & Bissell MJ 1995 The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. Journal of Clinical Investigation 95 859-873.
42. Russell PJ, Bennett S & Stricker P 1998 Growth factor involvement in progression of prostate cancer. Clinical Chemistry 44 705-723.
43. Scher HI, Sarkis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Fuks Z, Mendelsohn J & Cordon-Cardo C 1995 Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Clinical Cancer Research 1 545-550.
44. Shibahara T, Onishi T, Franco OE, Arima K & Sugimura Y 2005 Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells. Anticancer Research 25 1881-1888.
45. Singh A & Figg WD 2004 Upregulation of the androgen receptor during prostate cancer progression. Cancer Biology & Therapy 3 284-285.
46. Sugimura Y, Foster BA, Hom YK, Lipschutz JH, Rubin JS, Finch PW, Aaronson SA, Hayashi N, Kawamura J & Cunha GR 1996 Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. International Journal of Developmental Biology 40 941-951.
47. Takeda M, Arao T, Yokote H, Komatsu T, Yanagihara K, Sasaki H, Yamada Y, Tamura T, Fukuoka K, Kimura H et al. 2007 AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor. Clinical Cancer Research 13 3051-3057.
48. Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L et al. 2000 Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Cancer Journal 6 220-233.
49. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE & Rowley DR 2002a Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Research 62 3298-3307.
50. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD & Rowley DR 2002b Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clinical Cancer Research 8 2912-2923.
51. Udayakumar TS, Bair EL, Nagle RB & Bowden GT 2003 Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression. Molecular Carcinogenesis 38 70-77.
52. Uemura H, Ishiguro H, Nagashima Y, Sasaki T, Nakaigawa N, Hasumi H, Kato S & Kubota Y 2005 Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Molecular Cancer Therapeutics 4 1699-1709.
53. Verona EV, Elkahloun AG, Yang J, Bandyopadhyay A, Yeh IT & Sun LZ 2007 Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Research 67 5737-5746.
54. Wang D, Park JS, Chu JS, Krakowski A, Luo K, Chen DJ & Li S 2004 Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. Journal of Biological Chemistry 279 43725-43734.
55. Yan G, Fukabori Y, Nikolaropoulos S, Wang F & McKeehan WL 1992 Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Molecular Endocrinology 6 2123-2128.
56. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM & Ayala GE 2007 Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Human Pathology 38 1611-1620.